- Home
- Companies
- australasia
- blood flow
Refine by
Blood Flow Suppliers In Australasia
5 companies found
Manufacturerbased inSydney, AUSTRALIA
Uscom Limited (UCM) is an Australian founded, ASX listed innovative medical technology company specialising in development and global marketing of premium non-invasive cardiovascular and pulmonary medical devices. Uscom has a mission to demonstrate ...
USCOM 1A uses advanced Doppler hemodynamics to monitor cardiac blood flow. Stroke Volume (SV) monitoring changes the way we manage fluid, inotropes, and vaso-actives, and how we diagnose and manage sepsis, heart ...
Manufacturerbased inKalamazoo, MICHIGAN (USA)
We are a leader in emergency medical response and patient transport products. As your trusted EMS partner, we build solutions that help improve patient outcomes and caregiver safety, bringing more power to ...
Increase your power for advanced resuscitation. Deliver high-performance, continuous chest compressions with less strain, micromanagement, and risk for the caregiver. The LUCAS chest compression system provides benefits both to the cardiac arrest ...
Manufacturerbased inLeichhardt, AUSTRALIA
Baymatob is an Australian company specialising in the development of medical devices. The company was founded after the traumatic birth experience of CEO, Sarah McDonald, with her second child. It was this experience that made clear the need to do ...
Oli PPH is Baymatob's first AI-guided medical product based on the Oli maternity sensor, monitoring and diagnostic platform. Oli PPH is the only product to have ever demonstrated the ability to identify women who are at higher risk of developing ...
Manufacturerbased inToowong, AUSTRALIA
Anteris is a structural heart company delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. Our focus is on investing in and developing next-generation technologies with world class ...
The World’s First & Only 3D Single-piece Aortic Valve. DurAVR™ heart valve has the potential to deliver a functional cure in the treatment of Severe Aortic Stenosis. The unique design of DurAVR™ coupled with the ADAPT® ...
Manufacturerbased inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
Revascor is a Phase 3 product candidate being developed as a treatment for both advanced and end-stage chronic heart failure ...